FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092133085> ?p ?o ?g. }

• W2092133085 endingPage "192" @default.
• W2092133085 startingPage "183" @default.
• W2092133085 abstract "The use of interferon-α (IFN-α) in the treatment of infectious diseases has shown limited efficacy and dose-limiting toxicity. We have selected safe immunomodulators of the muramyl peptide family with the potential of enhancing the efficacy of IFN-α without resulting in increased toxicity. One of these synthetic muramyl dipeptide (MDP) derivatives, namely murabutide which is in a clinical stage of development, has been recently found to synergize with IFN-α2a in the selective induction of anti-inflammatory mediators and to enhance the biological activities of the therapeutic cytokine. The present study was performed to assess the antiviral activity of such muramyl peptides and a possible potentiation of the antiviral activity of IFN-α/β by associated therapy using the classical assay of Encephalomyocarditis virus (EMCV) infection. In vitro, pretreatment of Moloney Sarcoma virus (MSV)-transformed cell line with MDP derivatives followed by treatment with IFN-α/β showed a synergistic protection against the cytopathogenic effect of a subsequent EMCV infection. None of the MSV cultures could be protected by stimulation with muramyl peptides alone. In vivo, all of the muramyl peptide derivatives tested were found to be more potent than the parent molecule MDP in inducing protection against death or in the prolongation of the mean survival time of infected mice. Sequential administration of suboptimal doses of exogenous IFN-α/β and muramyl peptides established a strong antiviral state and considerably improved the protective effect of the cytokine, frequently leading to an abortive infection. Our findings suggest that combination therapy with safe muramyl peptides and IFN-α/β could constitute a highly effective and new regimen for the treatment of viral infections in humans." @default.
• W2092133085 created "2016-06-24" @default.
• W2092133085 creator A5000534105 @default.
• W2092133085 creator A5043722953 @default.
• W2092133085 creator A5055002173 @default.
• W2092133085 creator A5079177639 @default.
• W2092133085 creator A5090008345 @default.
• W2092133085 date "1996-03-01" @default.
• W2092133085 modified "2023-09-26" @default.
• W2092133085 title "Enhancement by muramyl peptides of the protective response of interferon-α/β against encephalomyocarditis virus infection" @default.
• W2092133085 cites W1927912260 @default.
• W2092133085 cites W1935071981 @default.
• W2092133085 cites W1978532986 @default.
• W2092133085 cites W1980525502 @default.
• W2092133085 cites W1980545493 @default.
• W2092133085 cites W1986969980 @default.
• W2092133085 cites W2002011994 @default.
• W2092133085 cites W2006930103 @default.
• W2092133085 cites W2011354388 @default.
• W2092133085 cites W2013746487 @default.
• W2092133085 cites W2026798219 @default.
• W2092133085 cites W2034522753 @default.
• W2092133085 cites W2035299947 @default.
• W2092133085 cites W2036717218 @default.
• W2092133085 cites W2046398686 @default.
• W2092133085 cites W2051161272 @default.
• W2092133085 cites W2059056468 @default.
• W2092133085 cites W2071386278 @default.
• W2092133085 cites W2072701951 @default.
• W2092133085 cites W2082529056 @default.
• W2092133085 cites W2088999388 @default.
• W2092133085 cites W2089298969 @default.
• W2092133085 cites W2127747971 @default.
• W2092133085 cites W2135538358 @default.
• W2092133085 cites W2148731066 @default.
• W2092133085 cites W2162126276 @default.
• W2092133085 cites W2341719041 @default.
• W2092133085 cites W2397167277 @default.
• W2092133085 doi "https://doi.org/10.1016/0192-0561(96)00005-7" @default.
• W2092133085 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8796446" @default.
• W2092133085 hasPublicationYear "1996" @default.
• W2092133085 type Work @default.
• W2092133085 sameAs 2092133085 @default.
• W2092133085 citedByCount "17" @default.
• W2092133085 countsByYear W20921330852018 @default.
• W2092133085 countsByYear W20921330852022 @default.
• W2092133085 crossrefType "journal-article" @default.
• W2092133085 hasAuthorship W2092133085A5000534105 @default.
• W2092133085 hasAuthorship W2092133085A5043722953 @default.
• W2092133085 hasAuthorship W2092133085A5055002173 @default.
• W2092133085 hasAuthorship W2092133085A5079177639 @default.
• W2092133085 hasAuthorship W2092133085A5090008345 @default.
• W2092133085 hasConcept C126322002 @default.
• W2092133085 hasConcept C150903083 @default.
• W2092133085 hasConcept C203014093 @default.
• W2092133085 hasConcept C207001950 @default.
• W2092133085 hasConcept C2522874641 @default.
• W2092133085 hasConcept C2776178377 @default.
• W2092133085 hasConcept C2776444769 @default.
• W2092133085 hasConcept C2778690821 @default.
• W2092133085 hasConcept C2779281246 @default.
• W2092133085 hasConcept C29730261 @default.
• W2092133085 hasConcept C55493867 @default.
• W2092133085 hasConcept C71924100 @default.
• W2092133085 hasConcept C86803240 @default.
• W2092133085 hasConcept C8891405 @default.
• W2092133085 hasConcept C98274493 @default.
• W2092133085 hasConceptScore W2092133085C126322002 @default.
• W2092133085 hasConceptScore W2092133085C150903083 @default.
• W2092133085 hasConceptScore W2092133085C203014093 @default.
• W2092133085 hasConceptScore W2092133085C207001950 @default.
• W2092133085 hasConceptScore W2092133085C2522874641 @default.
• W2092133085 hasConceptScore W2092133085C2776178377 @default.
• W2092133085 hasConceptScore W2092133085C2776444769 @default.
• W2092133085 hasConceptScore W2092133085C2778690821 @default.
• W2092133085 hasConceptScore W2092133085C2779281246 @default.
• W2092133085 hasConceptScore W2092133085C29730261 @default.
• W2092133085 hasConceptScore W2092133085C55493867 @default.
• W2092133085 hasConceptScore W2092133085C71924100 @default.
• W2092133085 hasConceptScore W2092133085C86803240 @default.
• W2092133085 hasConceptScore W2092133085C8891405 @default.
• W2092133085 hasConceptScore W2092133085C98274493 @default.
• W2092133085 hasIssue "3" @default.
• W2092133085 hasLocation W20921330851 @default.
• W2092133085 hasLocation W20921330852 @default.
• W2092133085 hasOpenAccess W2092133085 @default.
• W2092133085 hasPrimaryLocation W20921330851 @default.
• W2092133085 hasRelatedWork W1606529214 @default.
• W2092133085 hasRelatedWork W2009786324 @default.
• W2092133085 hasRelatedWork W2079763637 @default.
• W2092133085 hasRelatedWork W2081217596 @default.
• W2092133085 hasRelatedWork W2160010097 @default.
• W2092133085 hasRelatedWork W2178089606 @default.
• W2092133085 hasRelatedWork W2425440937 @default.
• W2092133085 hasRelatedWork W2521024263 @default.
• W2092133085 hasRelatedWork W3021018257 @default.
• W2092133085 hasRelatedWork W974381337 @default.
• W2092133085 hasVolume "18" @default.

• next